569
vs
ABT
569
ABT
Over the past 12 months, Vicplas International Ltd has significantly outperformed ABT, delivering a return of +12% compared to the ABT's 16% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
569
ABT
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Vicplas International Ltd
SGX:569
|
0.093
SGD
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
116.27
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
569, ABT
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Vicplas International Ltd
Revenue
|
|||||||||||
|
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
569, ABT
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Vicplas International Ltd
SGX:569
|
|||||||||
|
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vicplas International Ltd | ||||
|
|
Abbott Laboratories | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
569, ABT
Performance Gap
569, ABT
Performance By Year
569, ABT
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
